RA
Rishab Agarwal
About Rishab Agarwal
Data last updated:
Rishab Agarwal is a Director at Sabme Pharmaceuticals Private Limited (since 2018), Director at Aplosa Biotech Private Limited (since 2025) and Director at Dhisanalok Private Limited (since 2023), and holds 1 more current directorship. The companies operate in Engineering and Pharma. The largest current company by reported revenue is Sabme Pharmaceuticals Private Limited at ₹2.53 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 06 Dec 2018 | 2018 | ₹2.53 Cr (FY 2025) | Active | |
| Director | 11 Apr 2025 | 2025 | Active | ||
| Director | 06 Nov 2023 | 2023 | Active | ||
| Director | 11 Dec 2022 | 2022 | Active |
Board colleagues of Rishab Agarwal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Resham Kaur | 08296741 | Sabme Pharmaceuticals Private Limited | Director |
| Punam Verma | 11051739 | Aplosa Biotech Private Limited | Director |
| Pankhuri Agarwal | 10381566 | Dhisanalok Private Limited | Director |
| Rakhi Dey | 09819826 | Sammarsa Pharmaceutical Private Limited | Director |
| Sidhartha Dey | 09819825 | Sammarsa Pharmaceutical Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rishab Agarwal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rishab Agarwal
Rishab Agarwal currently holds 4 directorships: Sabme Pharmaceuticals Private Limited (Director, since 06 Dec 2018, revenue ₹2.53 Cr (FY 2025)); Aplosa Biotech Private Limited (Director, since 11 Apr 2025); Dhisanalok Private Limited (Director, since 06 Nov 2023); Sammarsa Pharmaceutical Private Limited (Director, since 11 Dec 2022).
Rishab Agarwal was first appointed on 06 Dec 2018 as Director at Sabme Pharmaceuticals Private Limited. The most recent appointment on record is 11 Apr 2025 at Aplosa Biotech Private Limited.
The current boards of Rishab Agarwal's companies include Resham Kaur (Sabme Pharmaceuticals Private Limited), Punam Verma (Aplosa Biotech Private Limited), Pankhuri Agarwal (Dhisanalok Private Limited), Rakhi Dey (Sammarsa Pharmaceutical Private Limited), Sidhartha Dey (Sammarsa Pharmaceutical Private Limited).